CABERPEX 1 - Sixpex

While Cabergoline’s primary application lies in treating prolactin-related disorders, it also serves as a secondary treatment for some Parkinson’s disease symptoms, given its role in stimulating dopamine receptors. This versatility highlights Cabergoline’s utility beyond prolactin management, though prolactin suppression remains its primary medical use. The ability of Cabergoline to act on dopamine receptors effectively extends its scope, making it a potential option in cases where dopamine agonism can relieve symptoms, though usually in lower doses than prolactin-specific treatments​.

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about CABERPEX 1 by Sixpex, consult with your doctor or healthcare professional.